Neuropsychology and Substance Use: State-of-the-Art and Future Directions

Contents
About the editors
List of contributors
From the series editor • Linas A. Bieliauskas
Preface • Ari Kalechstein and Wilfred G. van Gorp
1 Substance abuse epidemiology in the United States: A review of the indicator data • Jane C. Maxwell, Beth A. Rutowski, and Richard A. Rawson
Part I: Popular Drugs of Misuse
	2 Alcohol • Marlene Oscar-Berman and Ksenija Marinković
	3 Benzodiazepines • Simon F. Crowe and Melinda J. Barker
	4 Cocaine • Karen I. Bolla and Jean L. Cadet
	5 Marijuana • Raul Gonzalez, Eileen M. Martin, and Igor Grant
	6 MDMA • Ari Kalechstein, William E. Fantegrossi, Ronald L. Cowan, and James J. Mahoney
	7 Methamphetamine • Ari Kalechstein and Thomas F. Newton
	8 Nicotine • Heather G. Belanger, Vani Simmons, and John Schinka
	9 Opioids • Miriam Z. Mintzer and Matthew W. Johnson
Part II: Populations of Interest
	10 Substance use and neuropsychological disorders in aging • Dylan G. Harwood, Ari Kalechstein, and David L. Sultzer
	11 Neurobehavioral consequences of substance abuse and HIV infection • Michael R. Basso, Robert A. Bornstein, and Taeh Ward
	12 The neurocognitive consequences of substance use in schizophrenia: Are there additive effects? • Kari Tervo
Part III: Future Directions
	13 If only the hangover preceded intoxication: An integration of behavioral economic and neuropsychological approaches to impulsive choice • John R. Monterosso, Ari Kalechstein, and Xochitl Cordova
	14 The influence of environmental context on the effects of drugs of abuse • Jason M. Uslaner, Hans S. Crombag, and Terry E. Robinson
Author index
Subject index